Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Total Organic Carbon Method for Equipment Cleaning – V 2.0

Posted on By

Analytical Method Development: SOP for Total Organic Carbon Method for Equipment Cleaning – V 2.0

Standard Operating Procedure for Total Organic Carbon (TOC) Method Development in Equipment Cleaning Validation


Department Analytical Method Development
SOP No. SOP/AMD/235/2025
Supersedes SOP/AMD/235/2022
Page No. Page 1 of 13
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To describe a validated procedure for developing Total Organic Carbon (TOC) analytical methods for the detection and quantification of carbon-based residues on pharmaceutical

manufacturing equipment surfaces as part of cleaning validation and verification programs.

2. Scope

This SOP is applicable to the Analytical Method Development (AMD) department and is used in evaluating the effectiveness of cleaning procedures in removing organic residues, including product, excipients, and cleaning agents.

3. Responsibilities

  • Analytical Scientist: Designs and validates TOC methods and interprets results from rinse or swab samples.
  • QC Analyst: Performs replicate testing and supports TOC system calibration and maintenance.
  • QA Executive: Reviews validation reports and approves methods for GMP implementation.
See also  Analytical Method Development: SOP for Thermal Degradation Study Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the scientific validity, compliance, and implementation of TOC methods for cleaning validation programs.

5. Procedure

5.1 Instrument Setup and Calibration

  1. Use TOC analyzers with high sensitivity and capability to measure total carbon (TC), inorganic carbon (IC), and total organic carbon (TOC = TC − IC).
  2. Calibrate using standard potassium hydrogen phthalate (KHP) solutions at 0.5, 1.0, 2.5, and 5.0 ppm carbon.
  3. Perform system suitability using USP Reference Standards with recovery within ±15% of theoretical value.

5.2 Sample Collection

  1. Collect rinse samples from equipment using high-purity water (e.g., WFI) post-cleaning.
  2. Use pre-cleaned glass containers to avoid carbon contamination.
  3. Label and transport samples under nitrogen to minimize CO2 absorption.

5.3 Method Development

  1. Establish TOC limit based on:
    • Lowest Therapeutic Daily Dose (TDD) of previous product
    • Maximum allowable carryover (MACO)
    • TOC limit = (MACO / Equipment Surface Area) × Recovery Factor
  2. Optimize instrument parameters: carrier gas flow, combustion temperature, sample injection volume.

5.4 Method Validation

  1. Perform validation across following parameters:
    • Specificity: Demonstrate no interference from rinsing matrix
    • Linearity: r ≥ 0.990 in range 0.1 to 5 ppm
    • Accuracy: Recovery between 80–120%
    • Precision: %RSD ≤ 10%
    • LOD/LOQ: Determine based on signal-to-noise ratio (S/N ≥ 3 for LOD, S/N ≥ 10 for LOQ)
See also  Analytical Method Development: SOP for Linearity and Range Evaluation - V 2.0

5.5 Recovery Factor Evaluation

  1. Spike known amount of standard onto clean surface area and allow to dry.
  2. Rinse or swab the surface and analyze using TOC.
  3. Calculate recovery factor and include in calculation of TOC limit.

5.6 Documentation

  1. Record all calibration curves, validation data, recovery studies, instrument logs, and system suitability in Annexures.
  2. Prepare a TOC method validation report for QA approval.

6. Abbreviations

  • TOC: Total Organic Carbon
  • TC: Total Carbon
  • IC: Inorganic Carbon
  • MACO: Maximum Allowable Carryover
  • TDD: Therapeutic Daily Dose
  • RSD: Relative Standard Deviation

7. Documents

  1. TOC Calibration and Linearity Log – Annexure-1
  2. Recovery Factor Worksheet – Annexure-2
  3. TOC Method Validation Report – Annexure-3

8. References

  • USP <643> Total Organic Carbon
  • ICH Q7: GMP for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Cleaning Validation
  • WHO TRS 1025, Annex 8: Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Dr. Priya Sengupta Ankit Sharma Sunita Reddy
Designation TOC Analyst QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: TOC Calibration and Linearity Log

Concentration (ppm) Response Mean Value % RSD
0.5 38.2 38.5 2.3
1.0 78.5 78.7 1.9
2.5 195.3 194.8 2.5

Annexure-2: Recovery Factor Worksheet

Surface Spiked Carbon (µg) Recovered Carbon (µg) Recovery (%) Status
SS-316 50 45 90% Pass

Annexure-3: TOC Method Validation Report

The TOC method was validated for Ibuprofen equipment cleaning using WFI rinse. Linearity r = 0.994, accuracy 91–103%, and precision RSD 4.5%. Method deemed suitable for routine cleaning validation and verification.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included MACO-based TOC limit calculation and recovery factor validation Annual Review & Compliance Update Sunita Reddy
05/04/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for Osmolality Measurement in Sterile Products - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Operation and Cleaning of Semi-Automatic Tube Sealing Machine – V 2.0
Next Post: Biosimilars: SOP for Integrity Testing of Viral Filters – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version